These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36075963)

  • 1. The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder.
    Ben Hamida S; Sengupta SM; Clarke E; McNicholas M; Moroncini E; Darcq E; Ter-Stepanian M; Fortier MÈ; Grizenko N; Joober R; Kieffer BL
    Mol Psychiatry; 2022 Nov; 27(11):4662-4672. PubMed ID: 36075963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior.
    Meirsman AC; Ben Hamida S; Clarke E; de Kerchove d'Exaerde A; Darcq E; Kieffer BL
    eNeuro; 2019; 6(4):. PubMed ID: 31346000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.
    Meirsman AC; Le Merrer J; Pellissier LP; Diaz J; Clesse D; Kieffer BL; Becker JA
    Biol Psychiatry; 2016 Jun; 79(11):917-27. PubMed ID: 26188600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired working memory, cognitive flexibility and reward processing in mice genetically lacking Gpr88: Evidence for a key role for Gpr88 in multiple cortico-striatal-thalamic circuits.
    Thomson DM; Openshaw RL; Mitchell EJ; Kouskou M; Millan MJ; Mannoury la Cour C; Morris BJ; Pratt JA
    Genes Brain Behav; 2021 Feb; 20(2):e12710. PubMed ID: 33078498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors.
    Meirsman AC; Robé A; de Kerchove d'Exaerde A; Kieffer BL
    eNeuro; 2016; 3(4):. PubMed ID: 27570825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR88 in A
    Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM
    Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of Sensorimotor Brain Connectivity in Gpr88-Deficient Mice.
    Arefin TM; Mechling AE; Meirsman AC; Bienert T; Hübner NS; Lee HL; Ben Hamida S; Ehrlich A; Roquet D; Hennig J; von Elverfeldt D; Kieffer BL; Harsan LA
    Brain Connect; 2017 Oct; 7(8):526-540. PubMed ID: 28882062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N; Ganster T; O'Leary A; Popp S; Freudenberg F; Reif A; Soler Artigas M; Ribasés M; Ramos-Quiroga JA; Lesch KP; Rivero O
    Neuropharmacology; 2019 Sep; 156():107557. PubMed ID: 30849401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex.
    Rebeillard F; De Gois S; Pietrancosta N; Mai TH; Lai-Kuen R; Kieffer BL; Giros B; Massart R; Darmon M; Diaz J
    Cereb Cortex; 2022 Jan; 32(3):479-489. PubMed ID: 34247243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.
    Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA
    Elife; 2020 Jan; 9():. PubMed ID: 32003745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.
    Ehrlich AT; Semache M; Bailly J; Wojcik S; Arefin TM; Colley C; Le Gouill C; Gross F; Lukasheva V; Hogue M; Darcq E; Harsan LA; Bouvier M; Kieffer BL
    Brain Struct Funct; 2018 Apr; 223(3):1275-1296. PubMed ID: 29110094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
    Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M
    Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
    Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P
    Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks.
    Ben Hamida S; Mendonça-Netto S; Arefin TM; Nasseef MT; Boulos LJ; McNicholas M; Ehrlich AT; Clarke E; Moquin L; Gratton A; Darcq E; Harsan LA; Maldonado R; Kieffer BL
    Biol Psychiatry; 2018 Aug; 84(3):202-212. PubMed ID: 29580570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal GPR88 Modulates Foraging Efficiency.
    Rainwater A; Sanz E; Palmiter RD; Quintana A
    J Neurosci; 2017 Aug; 37(33):7939-7947. PubMed ID: 28729439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for the association of the NPSR1 gene A/T polymorphism (Asn107Ile) with impulsivity and hyperactivity.
    Laas K; Eensoo D; Paaver M; Lesch KP; Reif A; Harro J
    J Psychopharmacol; 2015 Aug; 29(8):878-83. PubMed ID: 25744621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics.
    Zimmermann AM; Jene T; Wolf M; Görlich A; Gurniak CB; Sassoè-Pognetto M; Witke W; Friauf E; Rust MB
    Biol Psychiatry; 2015 Jul; 78(2):95-106. PubMed ID: 24768258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NURR1 deficiency is associated to ADHD-like phenotypes in mice.
    Montarolo F; Martire S; Perga S; Spadaro M; Brescia I; Allegra S; De Francia S; Bertolotto A
    Transl Psychiatry; 2019 Aug; 9(1):207. PubMed ID: 31455763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.
    Li Y; Yin A; Sun X; Zhang M; Zhang J; Wang P; Xie R; Li W; Fan Z; Zhu Y; Wang H; Dong H; Wu S; Xiong L
    J Clin Invest; 2017 Dec; 127(12):4270-4284. PubMed ID: 29058689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology.
    Larsson H; Dilshad R; Lichtenstein P; Barker ED
    J Child Psychol Psychiatry; 2011 Sep; 52(9):954-63. PubMed ID: 21434915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.